HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 278215Erstellt: 26. Oktober 2026
Tert-butyl 4-(3,3-dibromoallyl)piperidine-1-carboxylate → Tert-butyl 4-(prop-2-yn-1-yl)piperidine-1-carboxylate
https://huagongshe.com/reaction/278215
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|
| Edukt | Tert-butyl 4-(3,3-dibromoallyl)piperidine-1-carboxylate | HCID 15503387 | — |
| Edukt | Butyllithium | HCID 178418339 | — |
| Lösungsmittel | Tetrahydrofuran | HCID 8028 | — |
| Produkt | Tert-butyl 4-(prop-2-yn-1-yl)piperidine-1-carboxylate | HCID 18187546 | 79,4% |
Reaktionsschritte
To a solution of 118 mg (0.31 mmol) of 1-(t-butoxycarbonyl)-4-(3,3-dibromoprop-2-en-1-yl)piperidine from Step A in THF (4 mL) at −78° C. was added a 2.5M solution of n-butyl lithium (0.370 mL, 0.92 mmol). After stirring at −78° C. for 45 min, the reaction mixture was quenched with sat'd ammonium chloride (4 mL) and diluted with ether (25 mL). After separating the phases, the aqueous layer was extracted with ether. The combined organic phases were washed with brine, dried over magnesium sulfate and concentrated. The residue was purified by FC (4:1 v/v hexanes/ether) to give the title compound (55 mg).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patentnummer | US06358979B1 |
|---|
| Quelldatensatz | uspto-grants-2002_03 |
|---|
| ORD ID | ord-f06c6eac3a3f4a698660b3098e5a9c4b |
|---|
| Quellennotiz | uspto-grants-2002_03 |
|---|